Nitric Oxide Synthase Inducible (Hepatocyte NOS or Inducible NO Synthase or Peptidyl Cysteine S Nitrosylase NOS2 or NOS Type II or NOS2 or EC 1.14.13.39) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Laminin-Deficient Congenital Muscular Dystrophy (LAMA2 MD or LAMA2-Related Muscular Dystrophy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Idiopathic (Essential) Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Low Affinity Immunoglobulin Gamma Fc Region Receptor III A (Fc Gamma RIII Alpha or IgG Fc Receptor III-2 or CD16a or FCGR3A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players